Login / Signup

Response to Comment on Ohkuma et al. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial. Diabetes Care 2017;40:1203-1209.

Toshiaki OhkumaMark WoodwardJohn Chalmersnull null
Published in: Diabetes care (2018)
Keyphrases
  • heart failure
  • left ventricular
  • phase iii
  • study protocol
  • clinical trial
  • phase ii
  • cardiac resynchronization therapy
  • stress induced
  • acute heart failure
  • open label